Tyrosine kinase inhibitors in HER2‐positive breast cancer brain metastases: A systematic review and meta‐analysis

BACKGROUND: Small tyrosine kinase inhibitors (TKIs) show activity against breast cancer brain metastases (BCBM) of the human epidermal growth factor receptor 2 (HER2)‐positive subtype. This meta‐analysis aimed to objectively explore the efficacy and safety of TKIs. METHODS: Electronic databases were...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yushuai, Huang, Kaiyan, Lin, Yuxiang, Zhang, Jie, Song, Chuangui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417165/
https://www.ncbi.nlm.nih.gov/pubmed/37255389
http://dx.doi.org/10.1002/cam4.6180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417165/
https://www.ncbi.nlm.nih.gov/pubmed/37255389
http://dx.doi.org/10.1002/cam4.6180

Ejemplares similares